D2-Dopaminergic Agonist Quinpirole and 8-Bromo-Camp have Opposite Effects on Goα Gtp-Binding Protein mRNA without Changing D2 Dopamine Receptor mRNA Levees in Striatal Neurones in Primary Culture

References

• Milligan G., Green A. Agonist control of G-protein levels. Trends Pharmacol. Sci. June, 1991; 207–209
   PubMedGoogle Scholar
• Hadcock J. R., Malbon C. C. Regulation of receptor expression by agonists: transcriptional and post-transcriptional controls. Trends in Neurosci. 1991; 14: 242–247
   PubMedGoogle Scholar
• Collins S., Caron M. G., Lefkowitz R. From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. Trends in Biochem. Sci. January, 1992; 17: 37–39
   PubMed Web of Science ®Google Scholar
• Muller P., Seeman P. Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 1978; 60: 1–11
   PubMed Web of Science ®Google Scholar
• Coirini H., Shumacher M., Angulo J. A., McEwen B. S. Increase in striatal dopamine D2 receptor mRNA after lesions or haloperidol treatment. Eur. J. Pharmacol. 1990; 186: 369–371
   PubMedGoogle Scholar
• Neve K. A., Neve R. L., Fidel S., Janowsky A., Higgins G. A. Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. Proc. Natl. Acad. Sci. USA 1991; 88: 2802–2806
   PubMedGoogle Scholar
• Van Tol H. H. M., Riva M., Civelli O., Creese I. Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level. Neurosci. Lett. 1990; 111: 303–308
   PubMedGoogle Scholar
• Jenner P., Marsden C. D. Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 1987; 26: 931–940
   PubMedGoogle Scholar
• Barton A. C., Black L. E., Sibley D. R. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells. Mol. Pharmacol. 1991; 39: 650–658
   PubMed Web of Science ®Google Scholar
• Ivins K. J., Luedtke R. R., Artymyshyn R. P., Molinoff P. B. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol. Pharmacol. 1991; 39: 531–539
   PubMed Web of Science ®Google Scholar
• Brabet P., Dumuis A., Sebben M., Pantaloni C., Bockaert J., Homburger V. Immunocytological localization of the guanine nucleotidebinding protein Go in primary cultures of neuronal and glial cells. J. of Neurosci. 1988; 8: 701–708
   PubMedGoogle Scholar
• Elazar Z., Siegel G., Fuchs S. Association of two pertussis toxinsensitive G-proteins with the D2-dopamine receptor from bovine striatum. EMBO J. 1989; 8: 2353–2357
   PubMedGoogle Scholar
• Lledo P. M., Homburger V., Bockaert J., Vincent J. D. Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells. Neuron 1992; 8: 455–463
   PubMed Web of Science ®Google Scholar
• Di Porzio U., Daguet M. C., Glowinski J., Prochiantz A. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 1980; 288: 370–373
   PubMedGoogle Scholar
• Maus M., Homburger V., Cordier J., Pantaloni C., Bockaert J., Glowinski J., Prémont J. Treatment of intact striatal neurones with cholera toxin or 8-bromoadenosine 3′,5′-(cyclic)phosphate decreases the ability of pertussis toxin to ADP-ribosylate the α-subunits of inhibitory and other guanine-nucleotidebinding regulatory proteins, Gi and Go. Eur. J. Biochem. 1991; 196: 313–320
   PubMedGoogle Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate – phenol – chloroform extraction. Analyt. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Faucon Biguet N., Buda M., Lamouroux A., Samolyk D., Mallet J. Time-course of the changes of TH mRNA in rat brain and adrenal medulla after a single injection of reserpine. EMBO J. 1986; 5: 287–291
   PubMedGoogle Scholar
• Jones D. T., Reed R. R. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J. Biol. Chem. 1987; 262: 14241–14249
   PubMed Web of Science ®Google Scholar
• Montmayeur J. P., Bausero P., Amlaiky N., Maroteaux L., Hen R., Borelli E. Differential expression of the mouse D2 dopamine receptor isoforms. FEBS Lett 1991; 278: 239–243
   PubMedGoogle Scholar
• Mastripolito R., Bendali M., Charon Y., Leblanc M., Martin B., Tricoire H., Valentin L. S. O. F. I.: a bidimensional detector for fast, direct, on line imaging of β-particles on blots. Biotechniques 1991; 6(11)778–785
   Google Scholar
• Bertrand P., Sanford J., Rudolph U., Codina J., Birnbaumer L. At least three alternatively spliced mRNAs encoding two α subunits of the Go GTP-binding protein can be expressed in a single tissue. J. Biol. Chem. 1990; 265: 18576–18580
   PubMedGoogle Scholar
• Rouot B., Charpentier N., Chabbert C., Carette J., Zumbihl R., Bockaert J., Homburger V. Specific antibodies against Go isoforms reveal the early expression of the Go2α subunit and appearance of Golα during neuronal differentiation. Mol. Pharmacol. 1992; 41: 273–280
   PubMedGoogle Scholar
• Weiss S., Sebben M., Garcia-Sainz J. A., Bockaert J. D2-dopamine receptor mediated inhibition of cyclic AMP formation in striatal neurons in primary culture. Mol. Pharmacol. 1985; 27: 595–599
   PubMedGoogle Scholar
• Chneiweiss H., Cordier J., Glowinski J. Cyclic AMP accumulation induces a rapid desensitization of the cyclic AMP-dependent protein kinase in mouse striatal neurons. J. Neurochem. 1991; 57: 1708–1715
   PubMedGoogle Scholar
• Guennoun R., Bloch B. D2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study. Dev. Brain Res. 1991; 60: 79–87
   PubMedGoogle Scholar
• Sales N., Martres M. P., Bouthenet M. L., Schwartz J. C. Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with (125I)Iodosulpride. Neurosci. 1989; 28(3)673–700
   Google Scholar
• Bruinink A., Lichtensteiger W., Schlumpf M. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain. J. Neurochem. 1983; 40: 1227–1236
   PubMed Web of Science ®Google Scholar
• Rao P. A., Molinoff P. B., Joyce J. N. Ontogeny of D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev. brain Res. 1991; 60: 161–177
   PubMedGoogle Scholar
• Weiner D. M., Levey A. I., Sunahara R. K., Niznik H. B., O'Dowd B. F., Seeman P., Brann M. R. D1 and D2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. USA 1991; 88: 1859–1863
   PubMed Web of Science ®Google Scholar
• Mack K. J., O'Malley K. L., Todd R. D. Differential expression of dopaminergic D2 receptor messenger RNAs during development. Dev. Brain Res. 1991; 59: 249–251
   PubMedGoogle Scholar
• Granneman J. G., Kapatos G. Developmental expression of Go in neuronal cultures from rat mesencephalon and hypothalamus. J. Neurochem. 1990; 54: 1995–2001
   PubMedGoogle Scholar
• Duman R. S., Saito N., Tallman J. F. Development of β-adrenergic receptor and G protein messenger RNA in rat brain. Mol. Brain Res. 1989; 5: 289–296
   PubMedGoogle Scholar
• Barton A. C., Sibley D. R. Agonist-induced desensitization of D1-dopamine receptors linked to adenylate cyclase activity in cultured NS20Y neuroblastoma cells. Mol. Pharmacol. 1990; 38: 531–541
   PubMed Web of Science ®Google Scholar
• Paulssen E. J., Paulssen R. H., Haugen T. B., Gautvik K. M., Gordeladze J. O. Regulation of G protein mRNA levels by thyroliberin, vasoactive intestinal peptide and somatostatin in prolactin-producing rat pituitary adenoma cells. Acta Physiol. Scand. 1991; 143: 195–201
   PubMedGoogle Scholar
• Longabaugh J. P., Didsbury J., Spiegel A., Stiles G. L. Modification of the rat adipocyte A1 receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of Gsα and Giα are not associated with changes in their mRNAs. Mol. Pharmacol. 1989; 36: 681–688
   PubMedGoogle Scholar
• Hadcock J. R., Port J. D., Malbon C. C. Cross-regulation between G-protein-mediated pathways. J. Biol. Chem. 1991; 266: 11915–11922
   PubMedGoogle Scholar
• Tsukamoto T., Toyama R., Itoh H., Kozasa T., Matsukoa M., Kaziro Y. Structure of the human gene and two rat cDNAs encoding the α chain of GTP-binding regulatory protein Go: Two different mRNAs are generated by alternative splicing. Proc. Natl. Acad. Sci. USA 1991; 88: 2974–2978
   PubMedGoogle Scholar
• Foulkes N. S., Borelli E., Sassone-Corsi P. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 1991; 64: 739–749
   PubMed Web of Science ®Google Scholar
• Mullaney I., Milligan G. Identification of two distinct isoforms of the guanine nucleotide binding protein Go in neuroblastoma x glioma hybrid cells: independent regulation during cyclic AMP-induced differentiation. J. Neurochem. 1990; 55: 1890–1898
   PubMedGoogle Scholar
• Von Euler G., Von Euler A. Dopamine D2 receptors attenuate phosphatidylinositol 4 5-bisphosphate in synaptosomal membranes from rat neostriatum. J. Neurochem. 1991; 56: 136–140
   PubMedGoogle Scholar
• Freedman J. E., Weight F. F. Single K+ channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum. Proc. Natl. Acad. Sci. USA 1988; 85: 3618–3622
   PubMedGoogle Scholar